Appraisals by Health Technology Assessment Agencies of Economic Evaluations Submitted as Part of Reimbursement Dossiers for Oncology Treatments: Evidence from Canada, the UK, and Australia

Publicly funded healthcare systems, including those in Canada, the United Kingdom (UK), and Australia, often use health technology assessment (HTA) to inform drug reimbursement decision-making, based on dossiers submitted by manufacturers, and HTA agencies issue publicly available reports to support...

Descripción completa

Detalles Bibliográficos
Autores principales: Ball, Graeme, Levine, Mitchell A. H., Thabane, Lehana, Tarride, Jean-Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600934/
https://www.ncbi.nlm.nih.gov/pubmed/36290879
http://dx.doi.org/10.3390/curroncol29100602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600934/
https://www.ncbi.nlm.nih.gov/pubmed/36290879
http://dx.doi.org/10.3390/curroncol29100602

Ejemplares similares